Personalized Medicine Market is expected to reach US$ 848.01 Bn. at a CAGR of 6.21% during the forecast period 2029.Personalized Medicine Market Overview:
The Personalized medicine is an emerging field of, medicine which is also referred to as precision medicine. This medical model uses an individual’s genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of disease. Knowledge of a patient's genetic profile can help doctors select the proper medication or therapy and administer it using the proper dose or regimen. Personalized medicine is being advanced through data from the Human Genome Project.To know about the Research Methodology :- Request Free Sample Report
Personalized Medicine Market Dynamics:
Dominantly increasing cases of various cancers worldwide primarily drive the market growth. The rising prevalence of cancer and the rising demand for personalized cancer therapeutics boost the market growth. Growing incidences of technological advancements owing to the accessibility of large scale human genome databases including Next Generation Sequencing (NGS) positively impacts market growth. The use of advanced computational tools and the development of innovative genetic technologies help in identifying cancer causes. Recent developments in pharmacogenomics are expected to create a suitable environment for developing drugs, which are specific to one patient or group. Increasing therapeutic applications in the fields like cardio-renal, neurology, antiviral, pulmonary, psychiatry are expected to create potential growth opportunity in forecast years. However, complex nature of these drugs, high development costs, and variability effects amongst the patients are some factors that may restrain the market growth. The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.Personalized Medicine Market Segment Analysis:
The global Personalized Medicine Market is segment on the basis of product, application, technology and end-users. Based on Product, the personalized nutrition & wellness segment held the largest share of xx% in 2022. It is expected to grow at a CAGR of 8.3% during the forecast period. Rising awareness of consuming healthy food for wellness, an increase in adoption of customized diet plans are considered to be the major factors propelling the segment growth. A wide range of nutrition & wellness products are available which play a significant role in boosting segment growth. In March 2021, DSM partnered with Mixfit to provide personalized nutrition solutions by combining Artificial Intelligence (AI) technology. Based on Technology, the drug discovery segment is expected to dominate the global market. Recent technological advancements in drug discovery and pharmacogenomics contribute to boosting the market growth. Pharmacogenomics is used in predicting the efficacy of a drug. Pharmacogenomics helps in focusing effective therapy on smaller patient subpopulations that, although demonstrate the same disease phenotype but have distinct genetic profiles. The segment is estimated to grow at a CAGR of 8.7% during the forecast period. In October 2021, Qiagen announced its launch of novel RNA-seq library preparation solutions for next-generation sequencing thereby expanding its portfolio and user base significantly.Regional Insights:
North America held a prominent market share of xx% in 2022. Due to Huge investments in the healthcare industry, the market for personalized medicine is expected to be dominated by the North America region followed by Europe. The increasing prevalence of cancer in the region and increased demand for precision medicine is attributed to the favorable government initiatives and growing investments for the development of novel solutions for effective disease management. Various initiatives undertaken will pave the market growth by creating awareness about personalized medicines.APAC is expected to grow at a significant CAGR during forecast period.
Owing to the low cost of clinical trials of newly developed precision medicines and diagnostic products. Moreover, rising disposable income levels and the growing economy of emerging countries will boost the market further. The report also helps in understanding Global Personalized Medicine Market dynamics, structure by analyzing the market segments and project the Global Personalized Medicine Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Personalized Medicine Market make the report investor’s guide.Personalized Medicine Market Scope: Inquire before buying
Global Personalized Medicine Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 556.21 Bn. Forecast Period 2023 to 2029 CAGR: 6.21% Market Size in 2029: US $ 848.01 Bn. Segments Covered: by Product Personalized Medical Care Therapeutics Personalized Nutrition & Wellness by Application Oncology Immunology CNS Respiratory by Technology Big Data Analytics Bioinformatics Gene Sequencing Drug Discovery Companion Diagnostics by End users Pharmaceutical Companies Diagnostic Companies Healthcare IT companies Personalized Medicine Market, by Region:
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Key Players
1. Abbott Laboratories 2. Merck & Co., Inc. 3. AstraZeneca 4. Pfizer, Inc. 5. GlaxoSmithKline plc. 6. Novartis AG 7. Amgen, Inc. 8. Bayer AG 9. Mylan N.V. 10. Eli Lilly and Company 11. Bristol Myers Squibb Co. 12. Daiichi Sankyo Company, Ltd. 13. Biogen, Inc. 14. Johnson & Johnson Services, Inc. 15. F. Hoffmann-La Roche Ltd. 16. Thermo Fisher Scientific, Inc. 17. Novo Nordisk A/S 18. Sanofi Genzyme.Frequently Asked Questions:
1. Which region has the largest share in Global Personalized Medicine Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Personalized Medicine Market? Ans: The Global Personalized Medicine Market is expected to grow at a CAGR of 6.21% during forecast period 2023-2029. 3. What is scope of the Global Personalized Medicine market report? Ans: Global Personalized Medicine Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Personalized Medicine market? Ans: The important key players in the Global Personalized Medicine Market are – Abbott Laboratories, Merck & Co., Inc., AstraZeneca, Pfizer, Inc., GlaxoSmithKline plc., Novartis AG, Amgen, Inc., Bayer AG, Mylan N.V., Eli Lilly and Company, Bristol Myers Squibb Co., Daiichi Sankyo Company, Ltd., Biogen, Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Novo Nordisk A/S, and Sanofi Genzyme.. 5. What is the study period of this market? Ans: The Global Personalized Medicine Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Personalized Medicine Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Personalized Medicine Market 3.4. Geographical Snapshot of the Personalized Medicine Market, By Manufacturer share 4. Global Personalized Medicine Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Personalized Medicine Market 5. Supply Side and Demand Side Indicators 6. Global Personalized Medicine Market Analysis and Forecast, 2022-2029 6.1. Global Personalized Medicine Market Size & Y-o-Y Growth Analysis. 7. Global Personalized Medicine Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 7.1.1. Personalized Medical Care 7.1.2. Therapeutics 7.1.3. Personalized Nutrition & Wellness 7.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.2.1. Oncology 7.2.2. Immunology 7.2.3. CNS 7.2.4. Respiratory 7.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 7.3.1. Big Data Analytics 7.3.2. Bioinformatics 7.3.3. Gene Sequencing 7.3.4. Drug Discovery 7.3.5. Companion Diagnostics 7.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 7.4.1. Pharmaceutical Companies 7.4.2. Diagnostic Companies 7.4.3. Healthcare IT companies 8. Global Personalized Medicine Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Personalized Medicine Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 9.1.1. Personalized Medical Care 9.1.2. Therapeutics 9.1.3. Personalized Nutrition & Wellness 9.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.2.1. Oncology 9.2.2. Immunology 9.2.3. CNS 9.2.4. Respiratory 9.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 9.3.1. Big Data Analytics 9.3.2. Bioinformatics 9.3.3. Gene Sequencing 9.3.4. Drug Discovery 9.3.5. Companion Diagnostics 9.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 9.4.1. Pharmaceutical Companies 9.4.2. Diagnostic Companies 9.4.3. Healthcare IT companies 10. North America Personalized Medicine Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Personalized Medicine Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 11.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 12. Canada Personalized Medicine Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 12.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 13. Mexico Personalized Medicine Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 13.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 14. Europe Personalized Medicine Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 14.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 15. Europe Personalized Medicine Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Personalized Medicine Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 16.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 17. France Personalized Medicine Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 17.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 18. Germany Personalized Medicine Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 18.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 19. Italy Personalized Medicine Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 19.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 20. Spain Personalized Medicine Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 20.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 21. Sweden Personalized Medicine Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 21.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 22. CIS Countries Personalized Medicine Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 22.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 23. Rest of Europe Personalized Medicine Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 23.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 24. Asia Pacific Personalized Medicine Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 24.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 25. Asia Pacific Personalized Medicine Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Personalized Medicine Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 26.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 27. India Personalized Medicine Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 27.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 28. Japan Personalized Medicine Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 28.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 29. South Korea Personalized Medicine Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 29.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 30. Australia Personalized Medicine Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 30.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 31. ASEAN Personalized Medicine Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 31.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 32. Rest of Asia Pacific Personalized Medicine Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 32.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 33. Middle East Africa Personalized Medicine Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 33.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 34. Middle East Africa Personalized Medicine Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Personalized Medicine Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 35.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 36. GCC Countries Personalized Medicine Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 36.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 37. Egypt Personalized Medicine Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 37.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 38. Nigeria Personalized Medicine Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 38.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 39. Rest of ME&A Personalized Medicine Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 39.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 40. South America Personalized Medicine Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 40.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 41. South America Personalized Medicine Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Personalized Medicine Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 42.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 43. Argentina Personalized Medicine Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 43.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 44. Rest of South America Personalized Medicine Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By Technology, 2022-2029 44.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Personalized Medicine Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Abbott Laboratories 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Merck & Co., Inc. 45.3.3. AstraZeneca 45.3.4. Pfizer, Inc. 45.3.5. GlaxoSmithKline plc. 45.3.6. Novartis AG 45.3.7. Amgen, Inc. 45.3.8. Bayer AG 45.3.9. Mylan N.V. 45.3.10. Eli Lilly and Company 45.3.11. Bristol Myers Squibb Co. 45.3.12. Daiichi Sankyo Company, Ltd. 45.3.13. Biogen, Inc. 45.3.14. Johnson & Johnson Services, Inc. 45.3.15. F. Hoffmann-La Roche Ltd. 45.3.16. Thermo Fisher Scientific, Inc. 45.3.17. Novo Nordisk A/S 45.3.18. Sanofi Genzyme 46. Primary Key Insights